Clinical Trial Update: Topical Autologous Serum Application for the Treatment of Corneal Epithelium Defect After Ocular Surgeries [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating topical autologous serum for treatment of corneal epithelial defects after ocular surgeries; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Epithelial Defect
• Diabetic Retinopathy

Drugs mentioned

• Topical Autologous Serum (autologous serum)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Corneal Epithelial Defect, Diabetic Retinopathy | Phase 1 | Status: COMPLETED | Results posted: 2010-09-02